Trastuzumab Recruiting Phase 1 / 2 Trials for Breast Cancer, Male / Cancer, Breast / Malignant Neoplasm of Female Breast / Her2-Positive Breast Cancer Treatment

IndicationsStatusPurposePhase
RecruitingTreatment1 / 2
clinicaltrials.gov IdentifierTitleDrugs
NCT01969643A Safety Study of SGN-LIV1A in Breast Cancer Patients
NCT03135171Trastuzumab and Pertuzumab in Combination With Tocilizumab in Subjects With Metastatic HER2 Positive Breast Cancer Resistant to Trastuzumab